Cargando…

Circulating MicroRNAs as Biomarkers for Sepsis

Sepsis represents a major cause of lethality during intensive care unit (ICU) treatment. Pharmacological treatment strategies for sepsis are still limited and mainly based on the early initiation of antibiotic and supportive treatment. In this context, numerous clinical and serum based markers have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benz, Fabian, Roy, Sanchari, Trautwein, Christian, Roderburg, Christoph, Luedde, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730322/ https://www.ncbi.nlm.nih.gov/pubmed/26761003 http://dx.doi.org/10.3390/ijms17010078

Ejemplares similares

Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness
por: Benz, Fabian, et al.
Publicado: (2015)

Role of circulating microRNAs in liver diseases
por: Loosen, Sven H, et al.
Publicado: (2017)

The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity
por: Schueller, Florian, et al.
Publicado: (2018)

Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis
por: Roderburg, Christoph, et al.
Publicado: (2013)

A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases
por: Roy, Sanchari, et al.
Publicado: (2018)

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis
por: Loosen, Sven H., et al.
Publicado: (2019)

A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)

Serum Levels of TNF Receptor Ligands Are Dysregulated in Sepsis and Predict Mortality in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2016)

Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma
por: Loosen, Sven H., et al.
Publicado: (2020)

Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2018)

Role of sepsis modulated circulating microRNAs
por: Szilágyi, Bernadett, et al.
Publicado: (2019)

U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
por: Benz, Fabian, et al.
Publicado: (2013)

miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years
por: Tacke, Frank, et al.
Publicado: (2019)

Circulating MicroRNAs: Potential Biomarkers for Cancer
por: Yu, De-Cai, et al.
Publicado: (2011)

Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer
por: Pombeiro, Ines, et al.
Publicado: (2018)

Circulating microRNAs as biomarkers - True Blood?
por: Schöler, Nathalie, et al.
Publicado: (2011)

Circulating microRNAs as biomarkers for Sepsis secondary to pneumonia diagnosed via Sepsis 3.0
por: Zhang, Wenping, et al.
Publicado: (2019)

Circulating MicroRNAs as Potential Biomarkers of Exercise Response
por: Polakovičová, Mája, et al.
Publicado: (2016)

Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers
por: Letelier, Pablo, et al.
Publicado: (2016)

Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer
por: Wang, Jin, et al.
Publicado: (2014)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC
por: Loosen, Sven H., et al.
Publicado: (2021)

Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment
por: Vucur, Mihael, et al.
Publicado: (2018)

Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2021)

Persistently elevated osteopontin serum levels predict mortality in critically ill patients
por: Roderburg, Christoph, et al.
Publicado: (2015)

Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation
por: da Silva, Ananília Medeiros Gomes, et al.
Publicado: (2017)

Serum Levels of miR-143 Predict Survival in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)

Circulating microRNAs as Biomarkers, Therapeutic Targets, and Signaling Molecules
por: Ajit, Seena K.
Publicado: (2012)

May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?
por: Wu, Xiaoling, et al.
Publicado: (2015)

Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
por: Wang, Hao, et al.
Publicado: (2018)

Circulating microRNAs in Medicine
por: Pozniak, Tetiana, et al.
Publicado: (2022)

Circulating MicroRNAs as Biomarkers of Acute Stroke
por: Sepramaniam, Sugunavathi, et al.
Publicado: (2014)

Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play
por: Sapre, Nikhil, et al.
Publicado: (2013)

Circulating microRNAs as potential new biomarkers for prostate cancer
por: Sita-Lumsden, A, et al.
Publicado: (2013)

Utility of Circulating MicroRNAs as Clinical Biomarkers for Cardiovascular Diseases
por: Kondkar, Altaf A., et al.
Publicado: (2015)

Circulating MicroRNAs as Clinical Biomarkers in the Predictions of Pregnancy Complications
por: Tsochandaridis, Marthe, et al.
Publicado: (2015)

Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022)

Accuracy of circulating microRNAs in diagnosis of sepsis: a systematic review and meta-analysis
por: Shen, Xiaomin, et al.
Publicado: (2020)

Role of microRNAs As Biomarkers in Sepsis-Associated Encephalopathy
por: Osca-Verdegal, Rebeca, et al.
Publicado: (2021)

Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer
por: Schou, Jakob Vasehus, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rik5p4mbtlgfgnfvo7k99i8ugf